New brain scan could spot Parkinson's protein buildup
NCT ID NCT07348250
First seen Jan 16, 2026 · Last updated Apr 23, 2026 · Updated 12 times
Summary
This early study tests a new imaging drug called [18F]MK-0947 that works with a PET scan to show clumps of a protein called alpha-synuclein in the brain, which are linked to Parkinson's disease. The goal is to see if the drug is safe and can help doctors better diagnose and track Parkinson's. The study includes 22 adults with Parkinson's and healthy volunteers, and involves PET scans, blood tests, and safety checks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON'S DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Invicro (dba Perceptive)
RECRUITINGNew Haven, Connecticut, 06510, United States
Contact Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.